🇺🇸 FDA
Patent

US 6287792

Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology

expired A61KA61K47/665A61K47/6898

Quick answer

US patent 6287792 (Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology) held by The Regents of the University of California expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K47/665, A61K47/6898